NextCure Inc
NASDAQ:NXTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NextCure Inc
NASDAQ:NXTC
|
US |
|
Osai Automation System SpA
MIL:OSA
|
IT |
|
Anima Holding SpA
MIL:ANIM
|
IT |
|
P
|
Playwith Inc
KOSDAQ:023770
|
KR |
|
Sunstone Metals Ltd
ASX:STM
|
AU |
|
H
|
Hacksaw AB
STO:HACK
|
SE |
|
I
|
Incyte Corp
XMUN:ICY
|
US |
|
S
|
Sumitomo Heavy Industries Ltd
F:SSM1
|
JP |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for NextCure Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What NextCure Does
NextCure is a clinical-stage biotechnology company that discovers and develops antibody-based drugs for cancer and other serious diseases. Its main work is to find immune-system targets that can be used to help the body fight tumors, then turn those targets into drug candidates that can be tested in patients. The company does not sell consumer products; it sells science and drug development programs.
- Headquarters
- United States of America US
- Employees
- 40
- IPO date
- May 9, 2019